Fortress Biotech, Inc. Other Current Liabilities
Fortress Biotech, Inc. (FBIO) had Other Current Liabilities of $268.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Liabilities, Current $268.00K.
- 2026-03-31: Other Liabilities, Current $268.00K.
- 2025-12-31: Other Liabilities, Current $135.00K.
- 2025-09-30: Other Liabilities, Current $135.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $268.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $268.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $135.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $135.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.07M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.14M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.50M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $163.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $163.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $163.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.35M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $268.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $996.00K 10-K · filed 2024-03-28 | $268.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | |
| 2020-12-31 | $5.30M 10-K/A · filed 2021-04-09 | |
| 2020-09-30 | $3.00M 10-Q · filed 2020-11-09 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-09 | |
| 2018-09-30 | $77.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $158.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.95M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $181.00K 10-Q · filed 2018-11-09 | |
| 2017-09-30 | $193.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $217.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $244.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $319.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $707.00K 10-Q · filed 2016-11-09 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | |
| 2014-09-30 | $500.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $500.00K 10-Q · filed 2014-08-11 | |
| 2013-12-31 | $500.00K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |